Meraw S J, Sheridan P J
Department of Dental Specialties, Mayo Clinic Rochester, MN 55905, USA.
Mayo Clin Proc. 1998 Dec;73(12):1196-9. doi: 10.4065/73.12.1196.
Gingival hyperplasia or gingival overgrowth is a common occurrence in patients taking phenytoin, cyclosporine, or calcium channel blockers. Speech, mastication, tooth eruption, and aesthetics may be altered. Controlling the inflammatory component through an appropriate oral hygiene program may benefit the patient by limiting the severity of the gingival overgrowth. In patients in whom gingival overgrowth is present or may be anticipated, recognition of this condition and referral to a general dentist or periodontist are appropriate steps to management. The physician's awareness of the potential for development of overgrowth and the dental practitioner's role in attempting to prevent or minimize this problem are important aspects. In this article, we discuss the medications associated with gingival hyperplasia and describe appropriate recommendations.
牙龈增生或牙龈过度生长在服用苯妥英钠、环孢素或钙通道阻滞剂的患者中很常见。言语、咀嚼、牙齿萌出和美观可能会受到影响。通过适当的口腔卫生计划控制炎症成分，可能会通过限制牙龈过度生长的严重程度而使患者受益。对于存在或可能出现牙龈过度生长的患者，认识到这种情况并转诊至普通牙医或牙周病医生是合适的管理步骤。医生对过度生长可能性的认识以及牙科从业者在试图预防或最小化此问题方面的作用是重要的方面。在本文中，我们讨论与牙龈增生相关的药物并描述适当的建议。
